Heparin-binding vitronectin up-regulates latent TGF-beta production by bovine aortic endothelial cells

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Ribeiro, S. M.
	Articles by Murphy-Ullrich, J. E.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Ribeiro, S. M.
	Articles by Murphy-Ullrich, J. E.


Social Bookmarking

	What's this?

Akama, T., Yamada, K. M., Seno, N., Matsumoto, I., Kono, I., Kashiwagi, H., Funaki, T. and Hayashi, M (1986). Immunological characterization of human vitronectin and its binding to glycosaminoglycans. J. Biochem 100, 1343-1351.

Antonelli-Orlidge, A., Saunders, K. B., Smith, S. R. and D'Amore, P. A (1989). An activated form of transforming growth factoris produced by cocultures of endothelial cells and pericytes. Proc. Nat. Acad. Sci. USA 86, 4544-4548.[Abstract/Free Full Text]

Assoian, R. K., Komoryia, A., Meyers, C. A., Miller, D. M. and Sporn, M. B (1983). Transforming growth factor-beta in human platelets. J. Biol. Chem 258, 7155-7160.[Abstract/Free Full Text]

Bascom, C. C., Wolfshohl, J. R., Coffey, Jr., R. J., Madisen, L., Webb, N. R., Purchio, A. R., Derynck, R. and Moses, H. L (1989). Complex regulation of transforming growth factor1, 2and3mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors 1and2. Mol. Cell. Biol 9, 5508-5515.[Abstract/Free Full Text]

Bittorf, S. V., Williams, E. C. and Mosher, D. F (1993). Alteration of vitronectin. Characterization of changes induced by treatment with urea. J. Biol. Chem 268, 24838-24846.[Abstract/Free Full Text]

Brown, P. D., Wakefield, L. M., Levinson, A. D. and Sporn, M. B (1990). Physiochemical activation of recombinant latent transforming growth factor betas 1, 2, and 3. Growth Factors 3, 35-43.[Medline]

Cadroy, Y., Houghten, R. A. and Hanson, S. R (1989). RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. J. Clin. Invest 84, 939-944.

Dallas, S. L., Park-Snyder, S., Myiazono, K., Twardzik, D., Mundy, G. R. and Bonewald, L. F (1994). Characterization and autoregulation of latent transforming growth factor-(TGF- ) complexes in osteoblast-like cell lines. J. Biol. Chem 269, 6815-6822.[Abstract/Free Full Text]

de Boer, H. C., Preissner, K. T., Bouma, B. N. and de Groot, P. G (1992). Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin. J. Biol. Chem 267, 2264-2268.[Abstract/Free Full Text]

Felding-Habermann, B. and Cheresh, D. A (1993). Vitronectin and its receptors. Curr. Opin. Cell Biol 5, 864-868.[Medline]

Gaido, K. W., Maness, S. C., Leonard, L. S. and Greele, W. F (1992). 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent regulation of transforming growth factors-and- 2expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control. J. Biol. Chem 267, 24591-24595.[Abstract/Free Full Text]

Gentry, L. E., Lioubin, M. N., Purchio, A. F. and Marquardt (1988). Molecular events in the processing of type I pre-pro-transforming growth factor beta to the mature polypeptide. Mol. Cell Biol 8, 4162-4168.[Abstract/Free Full Text]

Glick, A. B., Flanders, K. C., Danielpour, D., Yuspa, S. H. and Sporn, M. B (1989). Retinoic acid induces transforming growth factor-2 in cultured keratinocytes and mouse epidermis. Cell Regul 1, 87-97.[Medline]

Grinnell, F., Ho, C. H., Alumets, J. and Dahlback, B (1989). Immunohistochemical demonstration of age-related deposition of vitronectin (S-protein of complement) and terminal complement complex on dermal elastic fibers. J. Invest. Dermatol 92, 727-733.[Medline]

Hayman, E. C., Pierchbacher, M. D., Ohgre, Y. and Ruoslahti, E (1983). Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc. Nat. Acad. Sci. USA 80, 4003-4007.[Abstract/Free Full Text]

Heimark, R. L., Twardzik, D. R. and Schwarz, S. M (1986). Inhibition of endothelial cell regeneration by type-beta transforming growth factor from platelets. Science 233, 1078-1080.[Abstract/Free Full Text]

Hogasen, K., Mollnes, T. E. and Harboe, M (1992). Heparin-binding properties of vitronectin are linked to complex formation as illustrated by in vitro polymerization and binding to the terminal complement complex. J. Biol. Chem 267, 23076-23082.[Abstract/Free Full Text]

Holmes, R (1967). Preparation from human serum of an1protein which induces the immediate growth of unadapted cells in vitro. J. Cell Biol 32, 297-308.[Abstract/Free Full Text]

Ikeda, T., Lioubin, M. N. and Marquardt, H (1987). Human transforming growth factor type2: production by a prostatic adenocarcinima cell line, purification and initial characterization. Biochemistry 26, 2406-2410.[Medline]

Izumi, M., Yamada, K. M. and Hayashi, M (1989). Vitronectin exists in two structurally and functionally distinct forms in human placenta. Biochim. Biophys. Acta 990, 101-108.[Medline]

Kerl, J. H., Wakefield, L. M., Roberts, A. B., Jakowlew, S., Alvarez-Mon, M., Derynck, R., Sporn, M. B. and Fauci, A. S (1986). Production of transforming growth factorby human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med 163, 1037-1050.[Abstract/Free Full Text]

Keski-Oja, J., Leof, E. B., Lyons, R. M., Coffey, R. J. Jr and Moses, H. L (1987). Transforming growth factors and control of neoplastic cell growth. J. Cell Biochem 33, 95-107.[Medline]

Kim, S.-J., Jeang, K-T., Glick, A. B., Sporn, M. B. and Roberts, A. B (1989). Promoter sequences of the human transforming growth factor-1autoinduction. J. Biol. Chem 264, 7041-7045.[Abstract/Free Full Text]

Kim, S.-J., Glick, A. B., Sporn, M. B. and Roberts, A. B (1989). Characterization of the promoter region of the human transforming growth factor-1gene. J. Biol. Chem 264, 402-408.[Abstract/Free Full Text]

Kim, S.-J., Angel, P., Lafyatis, R., Hattori, K., Kim, K. Y., Sporn, M. B., Karin, M. and Roberts, A. B (1990). Autoinduction of transforming growth factor1 is mediated by the AP-1 complex. Mol. Cell. Biol 10, 1492-1497.[Abstract/Free Full Text]

Kim, S.-J., Park, K., Rudkin, B. B., Dey, B. R., Sporn, M. B. and Roberts, A. B (1994). Nerve growth factor induces transcription of transforming growth factor-1through a specific promoter element in PC12 cells. J. Biol. Chem 269, 3739-3744.[Abstract/Free Full Text]

Kornberg, L. J., Earp, H. S., Turner, C. E., Prockop, C. and Juliano, R. L (1991). Signal transduction by integrins: increased protein tyrosine phosphorilation caused by clustering of1 integrins. Proc. Nat. Acad. Sci. USA 88, 8392-8396.[Abstract/Free Full Text]

Kost, C., Stuber, W., Ehrlich, H. J., Pannekock, H. and Preissner, K. T (1992). Mapping of binding sites for heparin, plasminogen activator inhibitor-1 and plasminogen to vitronectin's heparin binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation. J. Biol. Chem 267, 12098-12105.[Abstract/Free Full Text]

Kovacina, K. S., Steele-Perkins, G., Purchio, A. F., Lioubin, M., Miyazono, K., Heldin, C.-H. and Roth, R. A (1989). Interactions of recombinant and platelet transforming growth factor-1precursor with the insulin-like growth factor/ mannose-6-phosphate receptor. Biochem. Biophys. Res. Commun 160, 393-403.[Medline]

Kubota, K., Katayama, S., Matsuda, M. and Hayashi, M (1988). Three types of vitronectin in human blood. Cell Struct. Funct 13, 123-128.[Medline]

Lyons, R. M., Keski-Oja, J. and Moses, H. L (1988). Proteolytic activation of latent transforming growth factor-from fibroblast-conditioned medium. J. Cell Biol 106, 1659-1665.[Abstract/Free Full Text]

Massague, J (1990). The transforming growth factor family. Annu. Rev. Cell Biol 6, 597-641.

McPherson, J., Sage, H. and Bornstein, P (1981). Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture: apparent identity with platelet thrombospondin. J. Biol. Chem 256, 11330-11336.[Abstract/Free Full Text]

Mosher, D. F., Doyle, M. J. and Jaffe, E. A (1982). Synthesis and secretion of thrombospondin by cultured endothelial cells. J. Cell Biol 93, 343-348.[Abstract/Free Full Text]

Murphy-Ullrich, J. E., Schultz-Cherry, S. and Hook, M (1992). Transforming growth factor-complexes with thrombospondin. Mol. Biol. Cell 3, 181-188.[Abstract]

Naski, M. C., Lawrence, D. A., Mosher, D. F., Podor, T. J. and Ginsburg, D (1993). Kinetics of inactivation of-thrombin by plasminogen activator inhibitor-1. Comparison of the effects of native and urea-treated forms of vitronectin. J. Biol. Chem 268, 12367-12372.[Abstract/Free Full Text]

Panetti, T. S. and McKeown-Longo, P. J (1993). Receptor-mediated endocytosis of vitronectin is regulated by its conformational state. J. Biol. Chem 268, 11988-11993.[Abstract/Free Full Text]

Panetti, T. S. and McKeown-Longo, P. J (1993). Thev 5integrin receptor regulates receptor-mediated endocytosis of vitronectin. J. Biol. Chem 268, 11492-11495.[Abstract/Free Full Text]

Pircher, R., Jullien, P. and Lawrence, D. A (1986). -transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem. Biophys. Res. Commun 136, 30-37.[Medline]

Preissner, K. T., Holzhuter, S., Justus, C. and Muller-Berghaus, G (1989). Identification and partial characterization of platelet vitronectin: evidence for complex formation with platelet-derived plasminogen activator inhibitor-1. Blood 74, 1989-1996.[Abstract/Free Full Text]

Raugi, G. J., Olerud, J. E. and Gown, A. M (1987). Thrombospondin in early human wound tissue. J. Invest. Dermatol 89, 551-554.[Medline]

Roberts, A. B., Anzano, M. A., Wakefield, L. M., Roche, N. S. and Sporn, M. B (1985). Type-transforming growth factor: a bifunctional regulator of cellular growth. Proc. Nat. Acad. Sci. USA 82, 119-123.[Abstract/Free Full Text]

Roberts, A. B. and Sporn, M. B (1988). Transforming growth factor. Advan. Cancer Res 51, 107-145.[Medline]

Sato, Y. and Rifkin, D. B (1989). Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-1-like molecule by plasmin during co-culture. J. Cell Biol 109, 309-315.[Abstract/Free Full Text]

Schultz-Cherry, S. and Murphy-Ullrich, J. E (1993). Thrombospondin causes activation of latent transforming growth factor-secreted by endothelial cells by a novel mechanism. J. Cell Biol 122, 923-932.[Abstract/Free Full Text]

Schultz-Cherry, S., Ribeiro, S., Gentry, L. and Murphy-Ullrich, J. E (1994). Thrombospondin binds and activates the small and large forms of latent transforming growth factor-in a chemically defined system. J. Biol. Chem 269, 26775-26782.[Abstract/Free Full Text]

Seiffert, D., Keeton, M., Eguchi, Y., Sawdey, M. and Loskutoff, D. J (1991). Detection of vitronectin mRNA in tissues and cells of the mouse. Proc. Nat. Acad. Sci. USA 88, 9402-9406.[Abstract/Free Full Text]

Seiffert, D., Crain, K., Wagner, N. V. and Loskutoff, D. J (1994). Vitronectin gene expression in vivo. Evidence for extrahepatic synthesis and acute phase regulation. J. Biol. Chem 269, 19836-19842.[Abstract/Free Full Text]

Shaffer, M. C., Foley, T. P. and Barnes, D. W (1984). Quantitation of spreading factor in human biologic fluids. J. Lab. Clin. Med 103, 783-791.[Medline]

Sporn, M. B., Roberts, A. B., Wakefield, L. M. and Assoian, R. K (1986). Transforming growth factor-: biological function and chemical structure. Science 233, 532-534.[Abstract/Free Full Text]

Stockmann, A., Hess, S., Declerck, P., Timpl, R. and Preissner, K. T (1993). Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein. J. Biol. Chem 268, 22874-22882.[Abstract/Free Full Text]

Tomasini, B. R. and Mosher, D. F (1988). Conformational states of vitronectin: preferential expression of an antigenic epitope when vitronectin is covalently and non-covalently complexed with thrombin-antithrombin III or treated with urea. Blood 72, 903-912.[Abstract/Free Full Text]

Tomasini, B. R., Owen, M. C., Fenton, J. W. II and Mosher, D. F (1989). Conformational lability of vitronectin: induction of an antigenic change by-thrombin-serpin complexes and by proteolytically modified thrombin. Biochemistry 28, 7617-7623.[Medline]

Van Obberghen-Schilling, E., Roche, N. S., Flanders, K. C., Sporn, M. B. and Roberts, A. B (1988). Transforming growth factor-1 positively regulates its own expression in normal and transformed cells. J. Biol. Chem 263, 7741-7746.[Abstract/Free Full Text]

Yorochko, A. D., Liu, D. Y., Eierman, D. and Haskill, S (1992). Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction. Proc. Nat. Acad. Sci. USA 89, 9034-9038.[Abstract/Free Full Text]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati

Twitter What's this?

This article has been cited by other articles:

G. G. Bishop, J. A. McPherson, J. M. Sanders, S. E. Hesselbacher, M. J. Feldman, C. A. McNamara, L. W. Gimple, E. R. Powers, S. A. Mousa, and I. J. Sarembock
Selective {{alpha}}v{beta}3-Receptor Blockade Reduces Macrophage Infiltration and Restenosis After Balloon Angioplasty in the Atherosclerotic Rabbit
Circulation, April 10, 2001; 103(14): 1906 - 1911.
[Abstract] [Full Text] [PDF]

H. M. Kwon, G. Sangiorgi, E. L. Ritman, A. Lerman, C. McKenna, R. Virmani, W. D. Edwards, D. R. Holmes, and R. S. Schwartz
Adventitial vasa vasorum in balloon-injured coronary arteries: Visualization and quantitation by a microscopic three-dimensional computed tomography technique
J. Am. Coll. Cardiol., December 1, 1998; 32(7): 2072 - 2079.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Ribeiro, S. M.

Articles by Murphy-Ullrich, J. E.

Search for Related Content

PubMed

PubMed Citation

Articles by Ribeiro, S. M.

Articles by Murphy-Ullrich, J. E.

Social Bookmarking

What's this?

				H. M. Kwon, G. Sangiorgi, E. L. Ritman, A. Lerman, C. McKenna, R. Virmani, W. D. Edwards, D. R. Holmes, and R. S. Schwartz Adventitial vasa vasorum in balloon-injured coronary arteries: Visualization and quantitation by a microscopic three-dimensional computed tomography technique J. Am. Coll. Cardiol., December 1, 1998; 32(7): 2072 - 2079. [Abstract] [Full Text] [PDF]